Product

Solnatide

Aliases

AP301, Solnatide 25 mg powder for reconstitution for solution for inhalation

1 clinical trial

1 indication

Indication

Clinical trial

Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS - a Randomised, Placebo-controlled, Double-blind Trial

Status: Recruiting, Estimated PCD: 2024-12-01